| Financial Year |
March 31 2023 |
| Monetary Funds |
1,164,673,953.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
46,154,193.54 |
| Accounts Receivable |
455,651,858.09 |
| Advances to Suppliers |
39,359,721.46 |
| Other Receivables |
4,937,659.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
320,821,205.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,995,541.19 |
| Total Current Assets |
2,121,465,111.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
525,373,520.48 |
| Under-construction Projects |
31,017,226.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,631,257.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,713,026.58 |
| Deferred Income Tax Assets |
15,695,102.94 |
| Other Non-Current Assets |
46,430,958.33 |
| Sub-Total of Non-Current Assets |
702,956,695.06 |
| Total Assets |
2,824,421,807.02 |
| Short-Term Loans |
200,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,477,608.40 |
| Accounts Payable |
462,106,270.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,411,672.25 |
| Taxes Payable |
10,755,237.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,924,446.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,010,721.32 |
| Other Current Liabilities |
16,289,099.74 |
| Sub-Total of Current Liabilities |
785,375,967.79 |
| Long-term Loans |
13,200,000.00 |
| Bonds Payable |
444,146,323.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,638,029.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
476,565,431.57 |
| Total Liabilities |
1,261,941,399.36 |
| Paid-In Capital(Or Share Stock) |
155,392,977.00 |
| Capital Surplus |
627,207,694.37 |
| Surplus Reserve |
63,841,971.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
661,260,612.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,562,480,407.66 |
| Owner's Equity（Stockholder's Equity） |
1,562,480,407.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,824,421,807.02 |
